Genome Wide Association Study of the Kynurenine Pathway
Abstract The kynurenine pathway (KP) of tryptophan metabolism plays a key role in physiological processes such as neuronal modulation, aging and immunity. Although genome-wide association studies (GWAS) have identified genetic determinants of selected kynurenine metabolites, the genetic architecture of the pathway as a whole remains incompletely characterized. We performed GWAS on nine KP metabolites and seven biologically informed metabolite-ratios measured by targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) in 4,871 unrelated individuals of Norwegian ancestry from the Hordaland Health Study. We identified 23 independent metabolite-associated loci (mQTLs), including associations for all measured metabolites covering all enzymes in the initial part of the pathway. Many signals replicated known loci at key pathway genes, including IDO1/2, AFMID, KMO, KYNU, HAAO, AADAT while revealing how their effects propagate across multiple pathway intermediates and ratios. Genetic associations were highly consistent with established pathway biology, with enzyme-specific loci predominantly affecting metabolites immediately upstream or downstream of the corresponding reaction. Ratio-based analyses identified additional hits not found by single-metabolite GWAS, reflecting pathway balance and vitamin B6-dependent enzymatic activity. Integration with expression quantitative trait locus data supported a dose-dependent role of KMO expression in regulating the kynurenic acid/quinolinic acid balance. We also identified novel loci that may represent important amino acid metabolism-immune crosstalk in the regulation of KP and previously unrecognized links with fatty acid oxidation, phase II transformation and metabolite efflux processes. Together, the study provides a comprehensive pathway-level view of the genetic determinants for circulating kynurenines and their ratios within a Northern European population.
Authors
- Øyvind Helgeland (ORCID: https://orcid.org/0000-0002-5612-2985)
- Pål R. Njølstad (ORCID: https://orcid.org/0000-0003-0304-6728)
- Adrian McCann (ORCID: https://orcid.org/0000-0002-5728-5321)
- Arve Ulvik (ORCID: https://orcid.org/0000-0003-1574-9690)
- Per Magne Ueland (ORCID: https://orcid.org/0000-0002-1903-0571)
- Tore Ivar Malmei Aarsland (ORCID: https://orcid.org/0000-0002-3185-3730)
- Jan Haavik (ORCID: https://orcid.org/0000-0001-7865-2808)
- Rolv Terje Lie (ORCID: https://orcid.org/0000-0001-6287-4051)
- Ottar Kjell Nygard (ORCID: https://orcid.org/0000-0002-4885-1010)
- Stefan Johansson (ORCID: https://orcid.org/0000-0002-2298-7008)
- Grete Seppola Tell
- Chinh B’krong Nguyen
Institutions
- Haukeland University Hospital (NO)
- Bevital (Norway) (NO)
- University of Bergen (NO)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-12
- DOI
- https://doi.org/10.21203/rs.3.rs-10957011/v1
- Primary Topic
- Tryptophan and brain disorders
- Type
- preprint
Funders
- Norges Teknisk-Naturvitenskapelige Universitet
- Novo Nordisk
- Helse Vest
- Universitetet i Bergen
- Norges Forskningsråd
- Bergens Forskningsstiftelse